Capex / revenue moved 206 bp higher
Capex / revenue changed +206 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed +206 basis points from the comparable as-filed period.
Capital expenditure changed +244.9% from the comparable as-filed period.
Cash & equivalents changed -82.6% from the comparable as-filed period.
Debt changed +15.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +225.9% from the comparable as-filed period.
Operating income changed +664.8% from the comparable as-filed period.
Operating margin changed +398 basis points from the comparable as-filed period.
Gross margin changed -80 basis points from the comparable as-filed period.
Revenue changed +7.6% from the comparable as-filed period.
Inventory changed +9.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Selling, general & administrative changed +7.8% from the comparable as-filed period.
Gross profit changed +2.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.